| Alywin E Kluttz, MD | |
|
100 Hospital Dr, Lebanon, MO 65536-9210 | |
| (417) 533-6100 | |
| (417) 533-6021 |
| Full Name | Alywin E Kluttz |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 100 Hospital Dr, Lebanon, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538165063 | NPI | - | NPPES |
| 201692530 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R4B87 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy East Ambulatory Services Llc | 2365739240 | 92 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Entity Name | Mercy Hospitals East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427098169 PECOS PAC ID: 1658276811 Enrollment ID: O20031209000789 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Entity Name | Mercy Hospitals East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285664177 PECOS PAC ID: 3779479019 Enrollment ID: O20040224001164 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073739041 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000058 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Entity Name | Mercy Hospital Lincoln |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962808733 PECOS PAC ID: 5193040020 Enrollment ID: O20150623002541 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Entity Name | Mercy East Ambulatory Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134673148 PECOS PAC ID: 2365739240 Enrollment ID: O20160920002054 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Entity Name | Scott City Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699472399 PECOS PAC ID: 2264699651 Enrollment ID: O20230223002765 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alywin E Kluttz, MD Po Box 504274, Saint Louis, MO 63150-4274 Ph: (417) 829-4620 | Alywin E Kluttz, MD 100 Hospital Dr, Lebanon, MO 65536-9210 Ph: (417) 533-6100 |
News Archive
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.
As states and cities struggle to resolve paralyzing budget shortfalls by sending workers on unpaid furloughs, freezing salaries and extracting larger contributions for health benefits and pensions, a growing number of public-sector workers are finding fewer reasons to stay.
› Verified 2 days ago
Rosana Mendoza Lim-javate, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 341 Hospital Dr., Family Health Associates, P.c., Lebanon, MO 65536 Phone: 417-588-3918 | |
Dr. Sailaja Tummala, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 755 Cowan Drive, Lebanon, MO 65536 Phone: 417-532-2805 Fax: 417-532-2865 | |
Dr. John C. Tabb, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 331 Hospital Dr, Suite C, Lebanon, MO 65536 Phone: 417-533-6500 Fax: 417-533-6555 | |
Jolene Ann Ostwinkle, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 341 Hospital Dr, Lebanon, MO 65536 Phone: 417-532-7850 Fax: 417-532-2451 | |
Dr. Jennifer S. Powell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Hospital Dr, Suite 100, Lebanon, MO 65536 Phone: 417-533-6751 Fax: 417-533-6755 | |
Dr. Philip V. Mitchell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Hospital Dr, Suite 100, Lebanon, MO 65536 Phone: 417-533-6751 Fax: 417-533-6755 | |
Dr. Mary A Kurek, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 510 Highway 32, Lebanon, MO 65536 Phone: 417-269-2278 Fax: 417-269-2274 |